Pharmaphie Holding SRL

Pharmaphie Holding reported total assets of €2.39m at the end of the 2025 financial year (annual accounts filed with the NBB on 22 Jun 2026).

Company number (CBE) 0847.262.435 · VAT BE0847262435
9051 Ghent
active in Activities of holding companies (NACE 64210)
operating since 03 Jul 2012 (≈ 14 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Pharmaphie Holding shows with a free account.

See the score
Profile
SRL since 2012
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result5,196 €
Equity705,767 €
Cash69,426 €
Total assets€2.39m
The line marks its sector median: 55.6% (18743 companies).

Change 2022 → 2025: Equity +17 % Total assets +16 %

Accounts of the company itself (not consolidated).

The full file covers 10 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Pharmaphie Holding's annual accounts

20252024202320222021
Net result5,196 €
Equity705,767 €
Cash69,426 €
Total assets€2.39m

Filed annual accounts

  • Year ended 31 Dec 2025filed on 22 Jun 2026
  • Year ended 31 Dec 2024filed on 14 Jul 2025
  • Year ended 31 Dec 2023filed on 02 Jul 2024
  • Year ended 31 Dec 2022filed on 03 Jul 2023
  • Year ended 31 Dec 2021filed on 07 Jul 2022

Pharmaphie Holding's financial analysis

Management and control of Pharmaphie Holding

2 active director(s) in the register.

Pharmaphie Holding's shareholders and holdings →

Pharmaphie Holding's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0847.262.435
VAT number
BE0847262435
Peppol
Registered · 0208:0847262435 · as of 10 Nov 2026
Legal form
SRL
Incorporated
03 Jul 2012
Registered office
9051 Ghent
Latest accounts
2025 · filed on 22 Jun 2026
Activity
Activities of holding companies (NACE 64210)

Pharmaphie Holding (SRL) has been based in Ghent since 2012, active in: activities of holding companies. For 2025, it reports a net profit of 5,196 € and equity of 705,767 €; its revenue is not published. Its solvency stands at 29.6%, below the median of its sector (55.6%).

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Pharmaphie Holding

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Pharmaphie Holding

What is the revenue of Pharmaphie Holding?

Pharmaphie Holding files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of Pharmaphie Holding?

In Belgium, the VAT number is the company number prefixed with BE: BE0847262435 for Pharmaphie Holding, if the company is VAT-registered. Its company number (CBE) is 0847.262.435.

Where is the registered office of Pharmaphie Holding?

According to the CBE register, the registered office of Pharmaphie Holding is in 9051 Ghent.

What is the equity of Pharmaphie Holding?

At the close of the 2025 financial year, the equity of Pharmaphie Holding amounts to 705,767 €, a solvency of 29.6% of total assets.

Who manages Pharmaphie Holding?

The register lists 2 active mandates at Pharmaphie Holding. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of Pharmaphie Holding

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 30 Aug 2026

No credit card, no commitment.

What each plan unlocks →